netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Certolizumab pegol found 7 matches
Open monograph to display formulary status BNF Category
  Certolizumab pegol  (Cimzia®) Musculoskeletal and joint diseases - Cytokine modulators - 10.01.03
  Certolizumab pegol  Skin - Drugs affecting the immune response - 13.05.03
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA 415 - Certolizumab pegol for treating rheumatoid arthritis after inadequate response to a TNF-alpha inhibitor (10.01.03)
link in subsection NICE TA375: Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed (10.01.03)
link in drug section NICE TA445: Certolizumab pegol and secukinumab for treating active psoriatic arthritis after inadequate response to DMARDs (10.01.03)
link in drug section NICE TA445: Certolizumab pegol and secukinumab for treating active psoriatic arthritis after inadequate response to DMARDs (10.01.03)
link in drug section NICE TA574: Certolizumab pegol for treating moderate to severe plaque psoriasis (10.01.03)


 
netFormulary